Company

Ultromics

vendor1 tracked tool

imaging_diagnostics category intelligence

Tracked Tools by Ultromics

Ultromics provides FDA-cleared AI-powered echocardiogram analysis that assists cardiologists in detecting heart failure with preserved ejection fraction and other cardiac conditions.

Company Intelligence

Ultromics secures £41m Series C funding to expand AI solution - Home | Digital Health

a month agofunding

Ultromics funding signal

2 months ago

Ultromics funding signal

2 months ago

Ultromics funding signal

2 months ago

Ultromics funding signal

2 months ago

Ultromics funding signal

2 months ago

AI-enhanced echocardiography improves early detection of amyloid buildup in the heart

5 months agoevidence

Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale

5 months agofda

EACVI and ASE Guidelines for Non-Invasive Imaging in Coronary Syndromes

5 months agodeployment

Oxford-based Ultromics secures £23.7M to help doctors diagnose cardiovascular disease through AI

5 months agodeployment

AI Tool Could Improve Early Detection of Cardiac Amyloidosis: Study

5 months agoevidence

Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale

5 months agofda

AI Early Diagnosis Could Save Heart and Cancer Patients

5 months agodeployment

Ultromics Raises €48 Million in Series C Funding

5 months agofunding

Ultromics Study Shows AI Could Improve Early Detection of Cardiac Amyloidosis

6 months agoevidence